GLP-1 Cost by State: Medicaid Coverage Map (2026)
Most state Medicaid programs do not cover GLP-1s for obesity. KFF counted 13 that did under fee-for-service as of January 2026, and some have since made changes. Below is what we can source for each state, with the date.
Correction, November 6, 2026: this page used to say 36 states covered GLP-1s for obesity. We could not source that, and KFF counted 13 as of January 2026. Each state now shows its source.
Our Records at a Glance
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
How Medicaid GLP-1 Coverage Works
State Medicaid programs must cover nearly all FDA-approved drugs, but a long-standing exception lets each state choose whether to cover weight-loss drugs. KFF describes coverage for obesity as optional for states, while coverage for other approved uses (diabetes, cardiovascular disease and sleep apnea) is required. KFF, January 16, 2026.
KFF's survey found 16 programs covering GLP-1s for obesity as of October 2025. It then reports that California, New Hampshire, Pennsylvania and South Carolina eliminated coverage and North Carolina reinstated it, for 13 as of January 2026.
The 13 Programs KFF Counted
These are the states on KFF's January 2026 map. The count is fee-for-service only:
Later changes we have on record: Rhode Island and Utah are marked not established, and Massachusetts is marked not covered. The table explains each one.
Full 50-State + DC Table
Status, source and the date each source describes. Read November 6, 2026.
| State | GLP-1s for obesity | Note |
|---|---|---|
| Alabama | Not covered | KFF's map lists Alabama as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Alaska | Not covered | KFF's map lists Alaska as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Arizona | Not covered | KFF's map lists Arizona as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Arkansas | Not covered | KFF's map lists Arkansas as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| California | Not covered | KFF's map lists California as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF says the state eliminated coverage after its October 2025 survey. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Colorado | Not covered | KFF's map lists Colorado as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Connecticut | Not covered | KFF's map lists Connecticut as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Delaware | Covered, Jan 2026 | KFF's map lists Delaware among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| District of Columbia | Not covered | KFF's map lists the District of Columbia as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Florida | Not covered | KFF's map lists Florida as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Georgia | Not covered | KFF's map lists Georgia as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Hawaii | Not covered | KFF's map lists Hawaii as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Idaho | Not covered | KFF's map lists Idaho as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Illinois | Not covered | KFF's map lists Illinois as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Indiana | Not covered | KFF's map lists Indiana as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Iowa | Not covered | KFF's map lists Iowa as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Kansas | Covered, Jan 2026 | KFF's map lists Kansas among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Kentucky | Not covered | KFF's map lists Kentucky as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Louisiana | Not covered | KFF's map lists Louisiana as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Maine | Not covered | KFF's map lists Maine as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Maryland | Not covered | KFF's map lists Maryland as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Massachusetts | Not covered | KFF counted Massachusetts among the 13 as of January 2026. WBUR reported on June 23, 2026 that MassHealth would end coverage for GLP-1 drugs for weight loss on July 1. We could not open MassHealth's own notice, so confirm with MassHealth or your plan. Source 1 Source 2 |
| Michigan | Covered, Jan 2026 | KFF's map lists Michigan among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. The RX Index, an independent tracker, later described Michigan's prior authorization as highly restrictive. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 Source 2 |
| Minnesota | Covered, Jan 2026 | KFF's map lists Minnesota among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Mississippi | Covered, Jan 2026 | KFF's map lists Mississippi among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Missouri | Covered, Jan 2026 | KFF's map lists Missouri among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Montana | Not covered | KFF's map lists Montana as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Nebraska | Not covered | KFF's map lists Nebraska as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Nevada | Not covered | KFF's map lists Nevada as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| New Hampshire | Not covered | KFF's map lists New Hampshire as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF says the state eliminated coverage after its October 2025 survey. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| New Jersey | Not covered | KFF's map lists New Jersey as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| New Mexico | Not covered | KFF's map lists New Mexico as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| New York | Not covered | KFF's map lists New York as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| North Carolina | Covered, Jan 2026 | KFF's map lists North Carolina among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. NC Medicaid says coverage for obesity was reinstated effective Dec. 12, 2025. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 Source 2 |
| North Dakota | Not covered | KFF's map lists North Dakota as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Ohio | Not covered | KFF's map lists Ohio as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Oklahoma | Not covered | KFF's map lists Oklahoma as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Oregon | Not covered | KFF's map lists Oregon as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Pennsylvania | Not covered | KFF's map lists Pennsylvania as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF says the state eliminated coverage after its October 2025 survey. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Rhode Island | Not established | KFF counted Rhode Island among the 13 as of January 2026. The RX Index, an independent tracker, reports a weight-loss exclusion scheduled for October 1, 2026. We could not open the state's notice, so we do not state a current answer. Confirm with Rhode Island Medicaid or your plan. Source 1 Source 2 |
| South Carolina | Not covered | KFF's map lists South Carolina as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF says the state eliminated coverage after its October 2025 survey. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| South Dakota | Not covered | KFF's map lists South Dakota as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Tennessee | Covered, Jan 2026 | KFF's map lists Tennessee among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Texas | Not covered | KFF's map lists Texas as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Utah | Not established | KFF counted Utah among the 13 as of January 2026 and noted that Utah reported funding for coverage was limited to FY 2026. The RX Index, an independent tracker, reports fee-for-service coverage for obesity alone ended June 30, 2026. We could not open the state's bulletin, so we do not state a current answer. Confirm with Utah Medicaid or your plan. Source 1 Source 2 |
| Vermont | Not covered | KFF's map lists Vermont as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Virginia | Covered, Jan 2026 | KFF's map lists Virginia among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Washington | Not covered | KFF's map lists Washington as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| West Virginia | Not covered | KFF's map lists West Virginia as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Wisconsin | Covered, Jan 2026 | KFF's map lists Wisconsin among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
| Wyoming | Not covered | KFF's map lists Wyoming as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Source 1 |
How to Check Your State's Coverage
- Call your Medicaid plan.KFF's count covers fee-for-service, and a managed care plan may differ. Call the number on your Medicaid card.
- Search your state's preferred drug list.Search for "[your state] Medicaid preferred drug list" and look for Wegovy, Zepbound or Saxenda.
- Ask your prescriber to run a benefits check. It looks at your own plan rather than general state policy.
- Contact your state agency. Medicaid.gov has a state contact list.
Medicare GLP-1 Bridge
The Medicare GLP-1 Bridge began July 1, 2026. Eligible Part D enrollees pay $50 a month for these drugs, per the Medicare fact sheet (June 2026):
- Covered: Foundayo (tablet), Wegovy (injection or tablet), Zepbound (KwikPen only). Zepbound vials and single-dose pens are not covered.
- BMI rule: 35 or higher; 30 or higher with certain heart failure, hard-to-control high blood pressure or stage 3a or higher chronic kidney disease; or 27 or higher with prediabetes or a prior heart attack, stroke or blocked arteries in the legs or arms.
- Not eligible: people with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, and people who can get a GLP-1 through their Medicare drug plan. Your plan may already cover a GLP-1 for these conditions.
- Approval: your doctor submits a form for approval from Medicare.
Read our Medicare GLP-1 Bridge guide for the source links.
Frequently Asked Questions
Why doesn't my state's Medicaid cover GLP-1s for weight loss?
Can Medicaid cover Ozempic if I have type 2 diabetes?
Is Medicaid coverage of GLP-1s for obesity growing or shrinking?
What does 'not established' mean?
What if my Medicaid doesn't cover GLP-1s for obesity?
What if I have both Medicare and Medicaid?
Find the Cheapest GLP-1 Option for You
Whether or not your Medicaid covers GLP-1s, compare recorded prices and savings programs.